Biotech

FDA © tcp Getty Images

Quarterly Round Up: CosmeticsDesign’s most popular articles

By Cassandra Stern

In our round up of the most popular articles from the recent business quarter, we’ve focused on news and trend developments in the North and South American beauty and personal care markets, including the FDA’s suspension of VCRP submissions, the launch...

cosmetic pigment production Debut Biotechnology DIC partnership

Debut Biotechnology partners with DIC on cosmetic pigment production

By Deanna Utroske

Biotech promises to be the future of chemical synthesis and is already used to manufacture numerous cosmetics and personal care ingredients. The Debut-DIC deal is on track to deliver not only a new source for cosmetics pigments but also to showcase a...

Amyris joins the menopause beauty movement

Amyris joins the menopause beauty movement

By Deanna Utroske

This month, the biotech company announced plans to add yet another consumer-facing business to its portfolio of cosmetics and personal care brands.

Elkimia accepts Government of Canada funding to expand

Elkimia Inc. accepts Government of Canada funding to expand

By Deanna Utroske

The sun care ingredient company is based in the National Research Council facility in Montreal, Québec. And thanks to the government’s economic recovery efforts, Elkimia is buying new equipment and developing more sun care actives.

© Anna Efetova / Getty Images

Givaudan outlines three huge opportunities for biotech in 2021

By Natasha Spencer

Biotechnology offers the opportunity for a more sustainable cosmetics industry, and wider acceptance of the technology will require giving consumers access to reliable information about the benefits, according to Givaudan.

© JuliaMikhaylova / Getty Images

Why hyaluronic acid is an “essential ingredient in skin care today”

By Natasha Spencer

With hyaluronic acid tipped to be a potential driving force in the upcoming beauty biotech revolution, we explore Croma Pharma’s 25-year use of the skin care ingredient and how it is still at the forefront of innovation as the brand launches its latest...

Amyris sells flavors and fragrance business to DSM

Amyris sells flavors and fragrance business to DSM

By Deanna Utroske

In a deal expected to close today, DSM is buying the synthetic biotechnology company’s flavor and fragrance intermediates business to augment its own aroma ingredients offerings and bring bio-based fragrance inputs to the cosmetics industry.

L’Oréal signs licensing deal w bacterial biotech firm Micreos

L’Oréal signs licensing deal with bacterial biotech firm Micreos

By Deanna Utroske

Under the agreement announced today, the Netherlands-based bacterial technology company will give L’Oréal access to a proprietary enzyme that targets and kills staphylococcus aureus—the endolysin is already an ingredient in Micreos’ own skin care brand...

Amyris produces CBG for skin care at commercial scale

Amyris produces CBG for skin care at commercial scale

By Deanna Utroske

Cannabinoid ingredients are increasingly popular in personal care. And with its engineered yeast and fermentation process, the biotech company Amyris is now equipped to manufacture cannabigerol, or CBG, commercially.

Sustainability matters more in 2020, shows new data

Sustainability matters more in 2020, shows new data

By Deanna Utroske

The California-based biotech company Genomatica has just released survey data on if and how much consumers in the US care about environmental issues during the COVID-19 health crisis.

Inc. recognizes privately owned beauty makers and suppliers

Inc. recognizes privately owned beauty makers and suppliers

By Deanna Utroske

The business magazine’s second annual list of Private Titans highlights 1,000 companies across industries that were once startups but have since grown in sales, employees, valuation and other indicators so as to standout in the private sector.